2011
Trinh XB, Tjalma WA, Dirix LY, Vermeulen PB, Peeters
DJ, Bachvarov D, Plante M, Berns EM, Helleman J, Van Laere SJ, van
Dam PA. Microarray-based oncogenic pathway profiling in advanced
serous papillary ovarian carcinoma. PLoS One.
2011;6(7):e22469.
Dirix LY, Van Dam PA, Prove AM, Vermeulen PB. Bevacizumab in the
treatment of patients with advanced breast cancer: where have we
landed? Ther Adv Med Oncol. 2010 Sep;2(5):331-42.
Sieuwerts AM, Mostert B, Bolt-de Vries J, Peeters D, de Jongh FE,
Stouthard JM, Dirix LY, van Dam PA, Van Galen A, de Weerd V, Kraan
J, van der Spoel P, Ramírez-Moreno R, van Deurzen CH, Smid M, Yu
JX, Jiang J, Wang Y, Gratama JW, Sleijfer S, Foekens JA, Martens
JW. mRNA and microRNA expression profiles in circulating tumor
cells and primary tumors of metastatic breast cancer patients. Clin
Cancer Res. 2011 Jun 1;17(11):3600-18.
Peeters DJ, Van den Eynden GG, van Dam PJ, Prové A, Benoy IH, van
Dam PA, Vermeulen PB, Pauwels P, Peeters M, Van Laere SJ, Dirix LY.
Circulating tumour cells in the central and the peripheral venous
compartment in patients with metastatic breast cancer. Br J Cancer.
2011 Apr 26;104(9):1472-7.
2010
Van der Auwera I, Yu W, Suo L, Van Neste L, van Dam
P, Van Marck EA, Pauwels P, Vermeulen PB, Dirix LY, Van Laere SJ.
Array-based DNA methylation profiling for breast cancer subtype
discrimination. PLoS One. 2010 Sep 7;5(9):e12616
Van der Auwera I, Limame R, van Dam P, Vermeulen PB, Dirix LY, Van
Laere SJ. Integrated miRNA and mRNA expression
profiling of the inflammatory breast cancer subtype. Br J Cancer.
2010 Aug 10;103(4):532-41
Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz
TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM,
Woodward WA, Yang WT, Ueno NT, Cristofanilli M.
International expert panel on inflammatory breast cancer: consensus
statement for standardized diagnosis and treatment. Ann Oncol. 2010
Aug 9
Van Laere S, Limame R, Van Marck EA, Vermeulen PB, Dirix
LY. Is there a role for mammary stem cells in
inflammatory breast carcinoma?: a review of evidence from cell
line, animal model, and human tissue sample experiments. Cancer.
2010 Jun 1;116(11 Suppl):2794-805
Vermeulen PB, van Golen KL, Dirix LY.
Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli
in inflammatory breast cancer: a review of the current knowledge.
Cancer. 2010 Jun 1;116(11 Suppl):2748-54.
Van der Auwera I, Bovie C, Svensson C, Trinh XB, Limame R, van Dam
P, van Laere SJ, van Marck EA, Dirix LY, Vermeulen
PB. Quantitative methylation profiling in tumor
and matched morphologically normal tissues from breast cancer
patients. BMC Cancer. 2010 Mar
12;10:97
Van der Auwera I, Peeters D, Benoy IH, Elst HJ, Van Laere SJ, Prové
A, Maes H, Huget P, van Dam P, Vermeulen PB, Dirix LY. Circulating
tumour cell detection: a direct comparison between the CellSearch
System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with
metastatic breast cancer.
Br J Cancer. 2009 010 Jan
19;102(2):276-84
2009
Trinh XB, van Dam PA, Dirix LY, Vermeulen PB, Tjalma WA. The
rationale for mTOR inhibition in epithelial ovarian cancer.
Expert Opin Investig Drugs. 2009 Dec;18(12):1885-91.
Van der Auwera I, Bovie C, Svensson C, Limame R, Trinh XB, van Dam
P, Van Laere SJ, Van Marck E, Vermeulen PB, Dirix LY. Quantitative
assessment of DNA hypermethylation in the inflammatory and
non-inflammatory breast cancer phenotypes.
Cancer Biol Ther. 2009 Dec 19;8(23)
Baldewijns MM, van Vlodrop IJ, Smits KM, Vermeulen PB, Van den
Eynden GG, Schot F, Roskams T, van Poppel H, van Engeland M, de
Bruïne AP. Different angiogenic potential in low and high grade
sporadic clear cell renal cell carcinoma is not related to
alterations in the von Hippel-Lindau gene.
Cell Oncol. 2009;31(5):371-82.
Vermeulen PB, Van Laere SJ, Dirix LY. Inflammatory breast carcinoma
as a model of accelerated self-metastatic expansion by
intravascular growth.
Br J Cancer. 2009 Sep 15;101(6):1028-9; author reply 1030
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Trinh XB, Van
Marck EA, Dirix LY, Vermeulen PB. Two distinct expression patterns
of urokinase, urokinase receptor and plasminogen activator
inhibitor-1 in colon cancer liver metastases.
Int J Cancer. 2009 Apr 23.
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Trinh XB, Van
Marck EA, Dirix LY, Vermeulen PB. Two distinct expression patterns
of urokinase, urokinase receptor and plasminogen activator
inhibitor-1 in colon cancer liver metastases.
Int J Cancer. 2009 Sep 15;125(6):1494-6.
Van Laere SJ, Elst H, Peeters D, Benoy I, Vermeulen PB, Dirix LY.
Re: Anti-epithelial cell adhesion molecule antibodies and the
detection of circulating normal-like breast tumor cells.
J Natl Cancer Inst. 2009 Jun 16;101(12):895-6; author reply
896-7.
Van der Auwera I, Elst HJ, Van Laere SJ, Maes H, Huget P, van Dam
P, Van Marck EA, Vermeulen PB, Dirix LY. The presence of
circulating total DNA and methylated genes is associated with
circulating tumour cells in blood from breast cancer
patients.
Br J Cancer. 2009 Apr 21;100(8):1277-86.
Van Laere SJ, Vermeulen PB, Dirix LY. cDNA microarray analysis of
inflammatory breast cancer signatures.
Methods Mol Biol. 2009;512:71-98.
Trinh BX, Tjalma WAA, Vermeulen PB, Van den Eynden GG, Van der
Auwera I, Van Laere SJ, Helleman J, Berns EMJJ, Dirix LY and van
Dam PA. The VEGF pathway and the AKT/mTOR/p70S6K1 signalling
pathway in human epithelial ovarian cancer.
Br J Cancer 2009 009 Mar 24;100(6):971-8.
Baldewijns MM, Roskams T, Ballet V, Van den Eynden GG, Van Laere
SJ, Van der Auwera I, Lerut E, De Bruïne AP, Thijssen VL, Vermeulen
PB, van Poppel H. A low frequency of lymph node metastasis in
clear-cell renal cell carcinoma is related to low lymphangiogenic
activity.
BJU Int. 2009 Jun;103(12):1626-31.
2008
Van Laere S, Beissbarth T, Van der Auwera I, Van den Eynden G,
Trinh XB, Elst H, Van Hummelen P, van Dam P, Van Marck E, Vermeulen
P, Dirix L. Relapse-free survival in breast cancer patients is
associated with a gene expression signature characteristic for
inflammatory breast cancer.
Clin Cancer Res. 2008 Nov 15;14(22):7452-60.
Van der Auwera I, Van Laere SJ, Van den Bosch SM, Van den Eynden
GG, Trinh BX, van Dam PA, Colpaert CG, van Engeland M, Van Marck
EA, Vermeulen PB, Dirix LY. Aberrant methylation of the Adenomatous
Polyposis Coli (APC) gene promoter is associated with the
inflammatory breast cancer phenotype.
Br J Cancer. 2008 Nov 18;99(10):1735-42.
Van den Eynden GG, Smid M, Van Laere SJ, Colpaert CG, Van der
Auwera I, Bich TX, van Dam P, den Bakker MA, Dirix LY, Van Marck
EA, Vermeulen PB, Foekens JA. Gene expression profiles associated
with the presence of a fibrotic focus and the growth pattern in
lymph node-negative breast cancer.
Clin Cancer Res. 2008 May 15;14(10):2944-52.
2007
Van den Eynden GG, Vandenberghe MK, van Dam PJ, Colpaert CG, van
Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Increased sentinel
lymph node lymphangiogenesis is associated with nonsentinel
axillary lymph node involvement in breast cancer patients with a
positive sentinel node. Clin Cancer Res. 2007 Sep 15;13(18 Pt
1):5391-7.
Van Laere S, Van der Auwera I, Van den Eynden G, Van Hummelen P,
van Dam P, Van Marck E, Vermeulen PB, Dirix L. Distinct molecular
phenotype of inflammatory breast cancer compared to
non-inflammatory breast cancer using Affymetrix-based genome-wide
gene-expression analysis. Br J Cancer. 2007 Oct
22;97(8):1165-74
Van den Eynden GG, Van der Auwera I, Colpaert CG, Dirix LY, Van
Marck EA, Vermeulen PB. Letter to the editor: Lymphangiogenesis in
primary breast cancer. Cancer Lett. 2007 Oct 28;256(2):279-81;
author reply 283-4.
Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van
Marck EA, Vermeulen PB, Dirix LY. NF-kappaB activation in
inflammatory breast cancer is associated with oestrogen receptor
downregulation, secondary to EGFR and/or ErbB2 overexpression and
MAPK hyperactivation. Br J Cancer. 2007 Sep 3;97(5):659-69.
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Trinh XB,
Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.
Comparison of molecular determinants of angiogenesis and
lymphangiogenesis in lymph node metastases and in primary tumours
of patients with breast cancer. J Pathol. 2007
Sep;213(1):56-64.
Van den Eynden GG, Colpaert CG, Couvelard A, Pezzella F, Dirix LY,
Vermeulen PB, Van Marck EA, Hasebe T. A fibrotic focus is a
prognostic factor and a surrogate marker for hypoxia and
(lymph)angiogenesis in breast cancer: review of the literature and
proposal on the criteria of evaluation. Histopathology. 2007
Oct;51(4):440-51.
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Gilles L, Burn
JL, Colpaert C, van Dam P, Van Marck EA, Dirix LY and Vermeulen PB.
Differential expression of hypoxia and (lymph)angiogenesis-related
genes at different metastatic sites in breast cancer. Clin Exp
Metastasis 2007 Feb 13
2006
Van den Eynden GG, Neyret A, Furney G, Rizk-Rabin M, Vermeulen PB,
Bouizar Z, Body JJ and Dirix LY. PTHrP, calcitonin and calcitriol
in a case of severe, protracted and refractory hypercalcemia due to
a pancreatic neuroendocrine tumor. Bone 2006 Dec 21
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Huygelen V,
Colpaert CG, van Dam P, Dirix LY, Vermeulen PB and Van Marck EA.
Induction of lymphangiogenesis in and around axillary lymph node
metastases of patients with breast cancer. Br J Cancer 2006 Nov 20;
95(10): 1362-6
Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB,
Harris AL, Dirix LY and Vermeulen PB. First international consensus
on the methodology of lymphangiogenesis quantification in solid
human tumours. Br J Cancer 2006 Dec 18;95(12):1611-25
Vermeulen PB, Van Laere SL, Dirix LY. How to measure and report the
estrogen (and progesterone) receptor in breast cancer. Int J
Gynecol Cancer. 2006 Sep-Oct;16 Suppl 2:529-32.
Dirix LY, Dam PV, Prove A, Vermeulen PB. Inflammatory breast
cancer: current understanding. Curr Opin Oncol. 2006
Nov;18(6):563-71.
Benoy IH, Elst H, Van Dam P, Scharpe S, Van Marck E, Vermeulen PB,
Dirix LY. Detection of circulating tumour cells in blood by
quantitative real-time RT-PCR: effect of pre-analytical time. Clin
Chem Lab Med. 2006;44(9):1082-7.
Van der Auwera I, Colpaert C, Van Marck E, Vermeulen P, Dirix L.
Lymphangiogenesis in breast cancer. Am J Surg Pathol. 2006
Aug;30(8):1055-6; author reply 1056-7.
Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpe S, Van
Marck E, Vermeulen PB, Dirix LY. Prognostic significance of
disseminated tumor cells as detected by quantitative real-time
reverse-transcriptase polymerase chain reaction in patients with
breast cancer. Clin Breast Cancer. 2006 Jun;7(2):146-52.
Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler
J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.
Nuclear factor-kappaB signature of inflammatory breast cancer by
cDNA microarray validated by quantitative real-time reverse
transcription-PCR, immunohistochemistry, and nuclear factor-kappaB
DNA-binding.Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3249-56.
Perryman LA, Blair JM, Kingsley EA, Szymanska B, Ow KT, Wen VW,
Mackenzie KL, Vermeulen PB, Jackson P, Russell PJ. Over-expression
of p53 mutants in LNCaP cells alters tumor growth and angiogenesis
in vivo. Biochem Biophys Res Commun. 2006 May 11; [Epub ahead of
print]
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, van
Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Distinguishing blood
and lymph vessel invasion in breast cancer: a prospective
immunohistochemical study. Br J Cancer. 2006 May 2; [Epub ahead of
print]
Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpe S, Van
Marck E,Vermeulen PB, Dirix LY. Real-time RT-PCR detection of
disseminated tumour cells in bone marrow has superior prognostic
significance in comparison with circulating tumour cells in
patients with breast cancer. Br J Cancer. 2006 Mar
13;94(5):672-680.
de Jong KP, Vermeulen PB, van Marck E, Boot M, Gouw AS. Endothelial
cell apoptosis in the context of quantification of angiogenesis in
solid human adenocarcinomas: A novel double immunolabelling
technique to identify endothelial cell apoptosis. Eur J Cancer.
2006 Jan;42(1):97-100. Epub 2005 Dec 5.
2005
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG,
Turley H, Harris AL, van Dam P, Dirix LY, Vermeulen PB and Van
Marck EA. Angiogenesis and hypoxia in lymph node metastases is
predicted by the angiogenesis and hypoxia in the primary tumour in
patients with breast cancer. Br J Cancer. 2005 Nov
14;93(10):1128-1136.
Van der Auwera I, Van den Eynden GG, Colpaert CG, Van Laere SJ, van
Dam P, Van Marck EA, Dirix LY and Vermeulen PB.Tumor
lymphangiogenesis in inflammatory breast carcinoma: a
histomorphometric study. Clin Cancer Res. 2005 Nov
1;11(21):7637-42.
Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M,
Van Dam P, Van Marck EA, Van Golen KL, Vermeulen PB and Dirix LY.
Identification of cell-of-origin breast tumor subtypes in
Inflammatory Breast Cancer by gene expression profiling. Breast
Cancer Res Treat. 2005 Oct 27;1-13 Epub ahead of print.
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van
Marck EA, van Dam P, Vermeulen PB, Dirix LY and van Golen KL.
Overexpression of caveolin-1 and -2 in cell lines and in human
samples of inflammatory breast cancer. Breast Cancer Res Treat.
2005 Oct 22;:1-10 [Epub ahead of print].
Luc Dirix, Peter Van Dam and Peter Vermeulen. Genomics and
circulating tumor cells: promising tools for choosing and
monitoring adjuvant therapy in patients with early breast cancer?
Current Opinion in Oncology 2005 Nov;17(6):551-558.
Baak JP, Colpaert CG, van Diest PJ, Janssen E, Diermen BV, Albernaz
E, Vermeulen PB, Van Marck EA. Related Articles, Links Multivariate
prognostic evaluation of the mitotic activity index and fibrotic
focus in node-negative invasive breast cancers. Eur J Cancer. 2005
Sep 6; [Epub ahead of print].
Van Laere S, Van der Auwera I, Van den Eynden GG, Fox SB, Bianchi
F, Harris AL, van Dam P, Van Marck EA, Vermeulen PB and Dirix LY.
Distinct molecular signature of inflammatory breast cancer by cDNA
microarray analysis. Breast Cancer Res. Treat. 2005 Aug 22; [Epub
ahead of print].
Sardari Nia P, Weyler J, Colpaert C, Vermeulen P, Van Marck E, Van
Schil P. Related Articles, Links Prognostic value of smoking status
in operated non-small cell lung cancer. Lung Cancer. 2005
Mar;47(3):351-9.
Benoy I, Salgado R, Elst H, Van Dam P, Weyler J, Van Marck E,
Scharpe S, Vermeulen P and Dirix L. Relative microvessel area of
the primary tumour, and not lymph node status, predicts the
presence of bone marrow micrometastases detected by reverse
transcriptase polymerase chain reaction in patients with clinically
non-metastatic breast cancer. Breast Cancer Res. Treat.
2005;7(2):R210-9. Epub 2005 Jan 10.
2004
Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, Van Dam
P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA,
Vermeulen PB and Dirix LY. Increased angiogenesis and
lymphangiogenesis in inflammatory versus non-inflammatory breast
cancer by real-time RT-PCR gene expression quantification. Clin
Cancer Res 2004, Dec 1;10(23):7965-71.
Van der Auwera I, Vermeulen P, Van Marck E, Dirix L. Lack of
lymphangiogenesis during breast carcinogenesis. J Clin Pathol. 2004
Dec;57(12):1342-3.
Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, Scharpé S,
Vermeulen PB, Dirix LY. Increased serum Interleukin-8 in patients
with early and metastatic breast cancer correlates with early
dissemination and survival. Clin Cancer Res. 2004 Nov
1;10(21):7157-62
Benoy IH, Elst H, Van der Auwera I, Van Laere S, van Dam P, Van
Marck E, Scharpé S, Vermeulen PB and Dirix LY. Real-time RT-PCR
correlates with immunocytochemistry for the detection of
disseminated epithelial cells in bone marrow aspirates of patients
with breast cancer. Br J Cancer. 2004 Nov 15;91(10):1813-20.
Sardari Nia P, Colpaert C, Blyweert B, Kui B, Vermeulen P, Ferguson
M, Hendriks J, Weyler J, Pezzella F, Van Marck E, Schil PV.
Prognostic value of nonangiogenic and angiogenic growth patterns in
non-small-cell lung cancer. Br J Cancer. 2004 Aug 24.
Salgado R, Benoy I, Vermeulen P, Van Dam P, Van Marck E, Dirix L.
Circulating Basic Fibroblast Growth Factor is Partly Derived from
the Tumour in Patients with Colon, Cervical and Ovarian Cancer.
Angiogenesis. 2004;7(1):29-32.
Salgado R, Vermeulen P, Dirix LY. Elevated perioperative serum
vascular endothelial growth factor levels in patients with colon
carcinoma. Cancer. 2004 Jul 15;101(2):431-2; author reply
432-3.
Weyn B, Tjalma WA, Vermeulen P, van Daele A, Van Marck E, Jacob W.
Determination of tumour prognosis based on angiogenesis-related
vascular patterns measured by fractal and syntactic structure
analysis. Clin Oncol (R Coll Radiol). 2004 Jun;16(4):307-16.
De Raeve HR, Vermeulen PB, Vanderkerken K, Harris AL, Van Marck E.
Microvessel density, endothelial-cell proliferation and carbonic
anhydrase IX expression in haematological malignancies, bone-marrow
metastases and monoclonal gammopathy of undetermined significance.
Virchows Arch. 2004 May; 445:27-35.
Stessels F, Van den Eynden G, Van der Auwera I, Salgado R, Van den
Heuvel E, Harris AL, Jackson DG, Colpaert CG, van Marck EA, Dirix
LY, Vermeulen PB. Breast adenocarcinoma liver metastases, in
contrast to colorectal cancer liver metastases, display a
non-angiogenic growth pattern that preserves the stroma and lacks
hypoxia. Br J Cancer. 2004 Apr 5;90(7):1429-36.
Van den Eynden GG, Van der Auwera I, Van Laere S, Colpaert CG, Van
Dam P, Merajver S, Kleer CG, Harris AL, Van Marck EA, Dirix LY,
Vermeulen PB. Validation of a tissue microarray to study
differential protein expression in inflammatory and
non-inflammatory breast cancer. Breast Cancer Res Treat. 2004
May;85(1):13-22.
2003
Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck
EA. The presence of a fibrotic focus in invasive breast carcinoma
correlates with the expression of carbonic anhydrase IX and is a
marker of hypoxia and poor prognosis. Breast Cancer Res Treat. 2003
Sep;81(2):137-47.
Sardari Nia P, Stessels F, Pezzella F, Vermeulen PB, van Marck EA,
van Schil P. Growth index is independent of microvessel density in
non-small cell lung carcinomas.Hum Pathol. 2003 Sep;34(9):959-60;
author reply 960-1.
Colpaert CG, Vermeulen PB, Dirix LY, Van Marck EA. Commentary re:
N. J. McCarthy et al., microvessel density, expression of estrogen
receptor alpha, MIB-1, p53 and c-erbB-2 in inflammatory breast
cancer. Clin. Cancer Res., 8: 3857-3862, 2002. Clin Cancer Res.
2003 Sep 1;9(10 Pt 1):3815-6; author reply 3816.
Colpaert CG, Vermeulen PB, Van Beest P, Soubry A, Goovaerts G,
Dirix LY, Harris AL, Van Marck EA. Cutaneous breast cancer deposits
show distinct growth patterns with different degrees of
angiogenesis, hypoxia and fibrin deposition. Histopathology. 2003
Jun;42(6):530-40.
Colpaert CG, Vermeulen PB, Benoy I, Soubry A, van Roy F, van Beest
P, Goovaerts G, Dirix LY, van Dam P, Fox SB, Harris AL, van Marck
EA. Inflammatory breast cancer shows angiogenesis with high
endothelial proliferation rate and strong E-cadherin expression. Br
J Cancer. 2003 Mar 10;88(5):718-25.
Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E,
Huget P, Dirix LY. Circulating interleukin-6 predicts survival in
patients with metastatic breast cancer. Int J Cancer. 2003 Feb
20;103(5):642-6.
2002
Salgado R, Benoy I, Weytjens R, Van Bockstaele D, Van Marck E,
Huget P, Hoylaerts M, Vermeulen P, Dirix LY. Arterio-venous
gradients of IL-6, plasma and serum VEGF and D-dimers in human
cancer. Br J Cancer. 2002 Dec 2;87(12):1437-44.
Van den Eynden GG, Colpaert CG, Vermeulen PB, Weyler JJ, Goovaerts
G, van Dam P, Van Marck EA, Dirix LY. Comparative analysis of the
biochemical and immunohistochemical determination of hormone
receptors in invasive breast carcinoma influence of the
tumor-stroma ratio. Pathol Res Pract. 2002;198(8):517-24.
Salgado R, Benoy I, van Marck E, Vermeulen P, Dirix L. The
importance of the VEGF-load in platelets in cancer patients. Ann
Oncol. 2002 Oct;13(10):1689-90.
Vermeulen PB, Fox SB, Dirix LY, Colpaert C, Van Marck EA.
Heterogeneity of vascularisation in invasive breast carcinoma. Eur
J Cancer. 2002 Sep;38(14):1951-2.
Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M,
Belien JA, de Waal RM, Van Marck E, Magnani E, Weidner N, Harris
AL, Dirix LY. Second international consensus on the methodology and
criteria of evaluation of angiogenesis quantification in solid
human tumours. Eur J Cancer. 2002 Aug;38(12):1564-79. Review.
Salgado R, Benoy I, Dirix L, Vermeulen P, Van Marck E. Importance
of platelets in VEGF-mediated angiogenesis in tumors. FEBS Lett.
2002 Jun 5;520(1-3):182.
Dirix LY, van Oosterom AT. Gene-expression profiling to classify
soft-tissue sarcomas. Lancet. 2002 Apr 13;359(9314):1263-4.
Vermeulen PB, Sardari Nia P, Colpaert C, Dirix LY, Van Marck E.
Lack of angiogenesis in lymph node metastases of carcinomas is
growth pattern-dependent. Histopathology. 2002
Jan;40(1):105-7.
Benoy I, Salgado R, Colpaert C, Weytjens R, Vermeulen PB, Dirix LY.
Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet
load in breast cancer patients. Clin Breast Cancer. 2002
Jan;2(4):311-5.
Dirix LY, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, van
Dam P, Prove A, Lemmens J, Vermeulen P. Plasma fibrin D-dimer
levels correlate with tumour volume, progression rate and survival
in patients with metastatic breast cancer. Br J Cancer. 2002 Feb
1;86(3):389-95.
2001
Salgado R, Benoy I, Bogers J, Weytjens R, Vermeulen P, Dirix L, Van
Marck E. Platelets and vascular endothelial growth factor (VEGF): a
morphological and functional study. Angiogenesis.
2001;4(1):37-43.
Colpaert C, Vermeulen P, Van Marck E, Dirix L.The presence of a
fibrotic focus is an independent predictor of early metastasis in
lymph node-negative breast cancer patients. Am J Surg Pathol. 2001
Dec;25(12):1557-8.
Colpaert C, Vermeulen P, van Beest P, Goovaerts G, Weyler J, Van
Dam P, Dirix L, Van Marck E. Intratumoral hypoxia resulting in the
presence of a fibrotic focus is an independent predictor of early
distant relapse in lymph node-negative breast cancer
patients.Histopathology. 2001 Oct;39(4):416-25.
Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H, Van Den
Heuvel E, Goovaerts G, Dirix LY, Van Marck E. Liver metastases from
colorectal adenocarcinomas grow in three patterns with different
angiogenesis and desmoplasia. J Pathol. 2001
Oct;195(3):336-42.
Salgado R, Vermeulen PB, Van Marck E, Benoy I, Dirix L.
Correspondence re: M. L. George et al., Correlation of plasma and
serum vascular endothelial growth factor levels with platelet count
in colorectal cancer: clinical evidence of platelet scavenging?
Clin. Cancer Res., 6: 3147-3152, 2000. Clin Cancer Res. 2001
May;7(5):1481-3.
Colpaert C, Vermeulen P, Jeuris W, van Beest P, Goovaerts G, Weyler
J, Van Dam P, Dirix L, Van Marck E. Early distant relapse in
"node-negative" breast cancer patients is not predicted by occult
axillary lymph node metastases, but by the features of the primary
tumour. J Pathol. 2001 Apr;193(4):442-9.